Study confirms close link between immune system and adult neurogenesis. News Medical, Published on August 19, 2014.
these findings would stimulate a new area of research into immune therapies to target neurological diseases
Friedreich Ataxia and close related scientific news. Topics related to rare diseases.
Saturday, August 23, 2014
More patients help drug companies pass valley of death - Indianapolis Business Journal
More patients help drug companies pass valley of death - Indianapolis Business Journal
But patient groups—especially those formed around rare and untreatable diseases—are indeed playing a crucial role in getting experimental drugs across the proverbial “valley of death”—where none of those deep-pocketed players want to put their money.
But patient groups—especially those formed around rare and untreatable diseases—are indeed playing a crucial role in getting experimental drugs across the proverbial “valley of death”—where none of those deep-pocketed players want to put their money.
Intellect Neurosciences, Inc. Issues Letter to Shareholders - GlobeNewswire press release
Intellect Neurosciences, Inc. Issues Letter to Shareholders - GlobeNewswire press release
Shire is developing OX1 as a treatment for Friedreich's Ataxia and possibly other diseases for which OX1 may qualify for orphan drug designation.
Shire is developing OX1 as a treatment for Friedreich's Ataxia and possibly other diseases for which OX1 may qualify for orphan drug designation.
Grant Alert: Hematopoietic Stem Cell-Based Therapy For Friedrich Ataxia (University Of California San Diego, La Jolla, United States)
Grant Alert: Hematopoietic Stem Cell-Based Therapy For Friedrich Ataxia (University Of California San Diego, La Jolla, United States). Project Leader: CHERQUI, STEPHANIE
The role of iron in neurodegenerative disorders: insights and opportunities with synchrotron light
The role of iron in neurodegenerative disorders: insights and opportunities with synchrotron light. Collingwood Joanna Frances, Davidson Mark Rogers, Front. Pharmacol., 19 August 2014 | doi: 10.3389/fphar.2014.00191
FULL TEXT PDF
FULL TEXT PDF